UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Lipoprotein(a), Cardiovascular Events and Sex Differences: A Single Cardiological Unit Experience

Journal of clinical medicine, 2023-01, Vol.12 (3), p.764

2023

Volltextzugriff (PDF)

“Eve is not Adam” – differences in efficacy, safety and clinical outcomes with lipoprotein apheresis between sexes

Endocrine, 2024, Vol.85 (1), p.233-237

2024

Volltextzugriff (PDF)

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure

Journal of Atherosclerosis and Thrombosis, 2017/08/01, Vol.24(8), pp.853-862

2017

Volltextzugriff (PDF)

Acute Increase in Ocular Microcirculation Blood Flow Upon Cholesterol Removal. The Eyes Are the Window of the Heart

The American journal of medicine, 2023-01, Vol.136 (1), p.108-114

2023

Volltextzugriff (PDF)

Adverse events and humoral response after two doses of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital personnel of a cardiopulmonary tertiary-care center

Infection control and hospital epidemiology, 2022-10, Vol.43 (10), p.1532-1534

2022

Volltextzugriff (PDF)

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?

Journal of geriatric cardiology : JGC, 2021-11, Vol.18 (11), p.973-974

2021

Volltextzugriff (PDF)

Widespread xanthomas regression by personalized lipid lowering therapy in heterozygous familial hypercholesterolemia

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2024-01, Vol.36 (1), p.35-37

2024

Volltextzugriff (PDF)

Gender difference in lipoprotein(a) concentration as a predictor of coronary revascularization in patients with known coronary artery disease

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2021-03, Vol.1866 (3), p.158869, Article 158869

2021

Volltextzugriff (PDF)

Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies

Journal of clinical apheresis, 2024-02, Vol.39 (1), p.e22094-n/a

2024

Volltextzugriff (PDF)

Comment on “Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling‐controlled case study on the efficacy of lipoprotein apheresis”

Journal of clinical apheresis, 2021-02, Vol.36 (1), p.219-220

2021

Volltextzugriff (PDF)

Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?

Transfusion and apheresis science, 2023-02, Vol.62 (1), p.103515-103515, Article 103515

2023

Volltextzugriff (PDF)

Doctors and their children: the Pandora's jar of infectious diseases

Minerva pediatrics, 2023-04, Vol.75 (2), p.299

2023

Volltextzugriff (PDF)

Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events

Revista portuguesa de cardiologia, 2022-09, Vol.41 (9), p.805-807

2022

Volltextzugriff (PDF)

A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors

European journal of preventive cardiology, 2020-12, Vol.27 (19), p.2284-2287

2020

Volltextzugriff (PDF)

COVID‐19 swab collection and serological screening in lipoprotein apheresis unit

Journal of clinical apheresis, 2020-08, Vol.35 (4), p.382-383

2020

Volltextzugriff (PDF)

Direct oral anticoagulants in lipoprotein apheresis: handle with care

Internal and emergency medicine, 2019-10, Vol.14 (7), p.1171-1173

2019

Volltextzugriff (PDF)

Elusive Therapeutic Effect of PCSK9 Inhibitors on Lipoprotein(a) Levels

Therapeutic apheresis and dialysis, 2019-08, Vol.23 (4), p.385-386

2019

Volltextzugriff (PDF)

PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study

Clinical drug investigation, 2020-02, Vol.40 (2), p.173-181

2020

Volltextzugriff (PDF)

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

Revista portuguesa de cardiologia, 2022-05, Vol.41 (5), p.437-439

2022

Volltextzugriff (PDF)

Lipoprotein(a) in familial hypercholesterolemia: Tips from family history

Revista portuguesa de cardiologia, 2021-03, Vol.40 (3), p.225-227

2021

Volltextzugriff (PDF)

Pitavastatin for cardiovascular health in patients with HIV infection

AIDS (London), 2024-02, Vol.38 (2), p.271

2024

Volltextzugriff (PDF)

Women and lipoprotein apheresis: another side of gender medicine

Endocrine, 2024-06

2024

Volltextzugriff (PDF)

High-risk NSTEMI due to Subclavian Artery Atherothrombosis in a Prior Coronary Artery Bypass Graft Patient

Journal of cardiovascular echography, 2019-04, Vol.29 (2), p.86-87

2019

Volltextzugriff (PDF)

Therapeutic adherence in hyperlipidemia: When one size doesn't fit all

European journal of internal medicine, 2023-06, Vol.112, p.143-145

2023

Volltextzugriff (PDF)

Therapeutic adherence in patients treated with PCSK9i: focus on skin side effects

Acta Cardiologica, 2024-02, p.1-2

2024

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(75)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Lipoprotein(a), Cardiovascular Events and Sex Differences: A Single Cardiological Unit Experience

“Eve is not Adam” – differences in efficacy, safety and clinical outcomes with lipoprotein apheresis between sexes

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure

Acute Increase in Ocular Microcirculation Blood Flow Upon Cholesterol Removal. The Eyes Are the Window of the Heart

Adverse events and humoral response after two doses of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital personnel of a cardiopulmonary tertiary-care center

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?

Widespread xanthomas regression by personalized lipid lowering therapy in heterozygous familial hypercholesterolemia

Gender difference in lipoprotein(a) concentration as a predictor of coronary revascularization in patients with known coronary artery disease

Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies

Comment on “Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling‐controlled case study on the efficacy of lipoprotein apheresis”

Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?

Doctors and their children: the Pandora's jar of infectious diseases

Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events

A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors

COVID‐19 swab collection and serological screening in lipoprotein apheresis unit

Direct oral anticoagulants in lipoprotein apheresis: handle with care

Elusive Therapeutic Effect of PCSK9 Inhibitors on Lipoprotein(a) Levels

PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

Lipoprotein(a) in familial hypercholesterolemia: Tips from family history

Pitavastatin for cardiovascular health in patients with HIV infection

Women and lipoprotein apheresis: another side of gender medicine

High-risk NSTEMI due to Subclavian Artery Atherothrombosis in a Prior Coronary Artery Bypass Graft Patient

Therapeutic adherence in hyperlipidemia: When one size doesn't fit all

Therapeutic adherence in patients treated with PCSK9i: focus on skin side effects

Suchergebnisse filtern